Status:
TERMINATED
The Effects of Filter During CPET on WOB and Aerosol Particle Concentrations
Lead Sponsor:
Rush University Medical Center
Collaborating Sponsors:
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Conditions:
Transmission, Patient-Professional
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Due to the concerns of virus transmission during COVID-19 pandemic, multiple respiratory societies postpone or limit pulmonary function test, especially cardiopulmonary exercise test (CPET), as patien...
Detailed Description
The subject will spend two visits one hour each day (\~ 1 hour) in the PFT lab and will have two separate CPET (Vmax Encore PFT System, Vyaire medical, Mettawa, IL) tests performed by registered pulmo...
Eligibility Criteria
Inclusion
- Ages 18-65, Male or Female
- Normal exercise tolerance without dyspnea or clinically important limitation of exercise tolerance.
Exclusion
- Complicated heart or lung disease
- Pregnancy
- Complex arrhythmias
- Severe Anemia
- Uncontrolled Diabetes, hypertension, or untreated thyroid disease
- Has any of the following symptoms in the last 21 days: sore throat, cough, chills, body aches for unknown reasons, shortness of breath for unknown reasons, loss of smell, loss of taste, fever at or greater than 100 degrees Fahrenheit.
- COVID-19 test positive within 21 days.
- Any Disease that the PI feels will markedly increase the risk of CPET testing
Key Trial Info
Start Date :
August 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 18 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04526925
Start Date
August 29 2020
End Date
September 18 2020
Last Update
April 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612